🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGLP-1/GIP receptor co-agonism — anyone have experience? Page 8

GLP-1/GIP receptor co-agonism — anyone have experience?

Dr.NephBHM_UK Thu, Apr 2, 2026 at 2:36 AM 36 replies 1,378 viewsPage 8 of 8
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Apr 16, 2026 at 2:11 AM#36
Dr.GutHealth said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

That reframing is the part I needed. Printing the relevant bit and taking it with me.

25 0DebRD_ATL, KristenIndy, MarkLI_maint and 22 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Apr 16, 2026 at 7:41 PM#37

Adding the clinical framing, because it changes how the question reads. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Apr 16, 2026 at 10:41 PM
24 24COA_Karl, MikeFit_NJ, InsuranceTom and 21 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Apr 17, 2026 at 1:11 PM#38
ingrid_STO said:
The version of this that has an answer is narrower than the version being asked.

Can confirm. Same sequence, different timescale.

23 23LarryQC_SD, wanda_boise, NurseAsh_DET and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Apr 18, 2026 at 6:42 AM#39
ingrid_STO said:
The version of this that has an answer is narrower than the version being asked.

Adding the part of the answer the thread has not reached. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

22 22alex_tucson, kevin_tulsa, Dr.PainCLE and 19 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Apr 19, 2026 at 12:13 AM#40

Adding the numbers, since they settle part of this. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

50 0jason_sac26, chris_chi24, tampaLisa73 and 47 others
Reply Quote Save Share Report
1678

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register